There were no significant differences in the risk of biliary cancer or hepatocellular carcinoma between GLP-1 RA users and other oral antidiabetic drug users
Opioids, in particular, are a well-known cause of constipation due to their effect on the gastrointestinal system, slowing bowel motility
Semaglutide for Weight Loss: GLP-1 Targeting Explained Semaglutide promotes weight loss by acting as a synthetic version of the GLP-1 hormone
Work in the lab of PS has been supported by Canada Research Chairs, Canada Foundation for Innovation, Alberta Prion Research Institute, Alberta InnovatesNovartis, MS Society of Canada, National MS Society, National Institutes of Health, Canadian Institutes for Health Research, the Hopewell M.I.N.D prize, Alzheimers Society, Barford Foundation, Krembil Foundation, and generous philanthropists